Agios Pharmaceuticals AGIO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$412.78M— | —— | -$352.09M— | —— | ||
| $5.18M-8.4% | $5.65M-14.6% | $6.62M-22.7% | $8.56M-7.3% | ||
| $52.55M+22.7% | $42.85M-4.3% | $44.77M-9.2% | $49.3M-7.9% | ||
| -$372.98M+4.3% | -$389.84M-31.7% | -$296.06M+4.3% | -$309.48M+24.0% | ||
| $4.32M+156% | $1.69M+68.2% | $1M-79.5% | $4.88M-15.3% | ||
| $377.18M— | —— | $239.58M-1.5% | $243.26M— | ||
| $8.68M-39.9% | $14.44M+166% | $5.43M+125% | $2.42M+100% | ||
| —— | -$11.96M— | —— | —— | ||
| -$377.29M+3.6% | -$391.53M-31.8% | -$297.06M+5.5% | -$314.36M+23.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Agios Pharmaceuticals generate?
- Agios Pharmaceuticals (AGIO) generated -$380.4M in operating cash flow over the trailing twelve months.
- What is Agios Pharmaceuticals's free cash flow?
- After $4.3M of capital expenditures, Agios Pharmaceuticals's free cash flow was -$384.7M over the trailing twelve months, up 4.7% year over year.
- Where does Agios Pharmaceuticals's cash flow data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
